Mechanistically, SOSTDC1 inhibits tumor progression by blocking the Wnt-β-catenin axis and facilitating T cell differentiation This finding suggests that SOSTDC1 is a potential prognostic biomarker for NSCLC bone metastasis (177). Here, SOSTDC1 is linked to neoplasm.